Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

sheep

FDA steps up fight against superbugs with livestock ruling

January 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, FDA, Guidelines, Livestock, agriculture, antibiotic resistance, farmers

The FDA began the year by announcing the implementation of ‘Guidance for Industry #213’. The new rule is a voluntary …
News
alessandro-riva

Gilead makes move in oncology by snaffling Riva from Novartis

January 4, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, Novartis, oncology

Gilead Sciences have made an ambitious move to boost its oncology business by appointing current head of global oncology development …
Appointment
sun_pharma

Blast at Sun Pharma factory kills two

January 4, 2017 Medical Communications, Research and Development Sun Pharma, factory, fire

A blast at Sun Pharma’s Ahmednagar factory caused the deaths of two workers and injured a further two. The four …
News
amgen_hq

Amgen’s patent win upheld against Sanofi-Regeneron

January 4, 2017 Medical Communications, Research and Development Amgen, Regeneron, Sanofi, patent

In March 2016, Amgen won two major patent cases against Sanofi and Regeneron over their drug, Praleunt, after it was …
News
texas-star

Texas launches lawsuit against FDA over lethal drug shipment

January 4, 2017 Medical Communications, Research and Development FDA, texas

The state of Texas has filed a lawsuit against the FDA to try to force a decision to be made …
News
novartis_window

Greek authorities raid Novartis’ offices after bribery allegations

January 4, 2017 Medical Communications, Research and Development Greece, Greek, Novartis, bribery

The investigation into practices by Novartis in its Greek operations has been accelerated after the attempted suicide of a Greek …
News
giovanni_caforio

Giovanni Caforio to be made chairman of the board at BMS

January 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myers Squibb, Giovanni Caforio, bristol myers-squibb

Bristol-Myers Squibb has announced that Giovanni Caforio has been appointed chairman of the board. Caforio will take up the position …
Appointment
seattle_genetics

Four die in Seattle Genetics’ drug trial

January 3, 2017 Manufacturing and Production, Medical Communications, Sales and Marketing Seattle Genetics, patient deaths, trial hold

Seattle Genetics released that the FDA had placed a hold had been placed on clinical trials involving its experimental cancer …
News

Pfizer announces acquisition of small-molecule business from AZ for $550 million

December 23, 2016 Medical Communications AstraZeneca, Pfizer

Pfizer has announced that they have acquired AstraZeneca’s small molecule anti-infectives business for an upfront fee of $550 million. Pfizer …
News
logo_bial

French clinical trial tragedy did not check all data

December 23, 2016 Medical Communications Bial

There have been new revelations regarding the fatal French clinical trial that occurred in January of this year. Nature reports …
News
teva_copy

Teva hit with record fine $519 million corruption fine

December 23, 2016 Medical Communications Teva, corruption, fine

Teva Pharmaceuticals, the world’s largest generics company, has been hit with the largest criminal fine to come from the US …
News
business

2016 Top markets report

December 23, 2016 Medical Communications market, market access

2016 Top Markets Report
News
top_ten_1

Top Ten most popular articles on Pharmafile.com this year

December 23, 2016 Medical Communications biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

As we’re now in the New Year, here at Pharmafocus, we thought we would do a recap of the ten …
News
merrimack-pharmaceuticals

Merrimack’s breast cancer trial stutters to halt

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merrimack Pharmaceuticals, merrimack

Merrimack Pharmaceuticals announced that it had decided to stop a Phase 2 study of MM-302, a HER2 antibody-targeted liposomal doxorubicin, …
News
frederik_wilkinson

Impax Laboratories parts with CEO

December 22, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Impax Laboratories

Impax Laboratories announced on 20 December that CEO Frederik Wilkinson has left his position of president and CEO, as well …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026